|
|
 |
|
Viewing report
|
|
|
|
COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact
Lead Discovery, Oct 2004, Pages: 59
Customers who bought this item also bought
COX-2 Inhibitors - Biology, Therapeutic Agents & Markets
Vioxx Recall - Revenue Analysis and Impact on Cox-2 Inhibitor Markets
Event Analysis and Response Service: Cox-2s - Cox-2 Crisis Dents Big Pharma Confidence
The Vioxx Withdrawal: Changes and Opportunities for the Industry
Drug Safety in the Post-Vioxx Era: New Legislation, Regulation and Company Strategies in Europe and the US
The Future of Cox-ii Inhibitors: Market Challenges and Pipeline Initiatives
Global market size for arthritis medications by number of prescriptions and by sales in US dollars, with breakout of sales and percent market share for Celebrex / Valdecoxib and Vioxx / Etoricoxib coxib ( COX-2 specific inhibitor ) drugs in 2000 fore
US VIOXX Litigation Update Call - Merck & Co., Inc. - Earnings Transcript
Sales of Cox-2 Inhibitors, 1999-2004
The Global Pain Therapeutics Market, 3rd Edition - Market Analysis, R&D Pipelines and Competitive Landscape
Competitor Analysis: HDAC Inhibitors
Competitor Analysis: PARP Inhibitors
|
|
|
|
